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Abstract
Objectives: Pancreaticoduodenectomy (PD) is associated with high morbidity, in part as a result of
infectious complications increased by preoperative bile contamination. The aim of the present study was
to assess the effect on the incidence of infectious complications of short-term antimicrobial therapy (AMT)
in high-risk patients.
Methods: Patients with a high risk for positive intraoperative bile culture (i.e. those with ampulloma or
pancreatic adenocarcinoma with preoperative endoscopic procedures) (high-risk group, n = 99) were
compared with low-risk patients (i.e. those with pancreatic adenocarcinoma without preoperative endo-
scopic procedures) (low-risk group, n = 76). The high-risk group received a 5-day course of perioperative
AMT secondarily adapted to the bile antibiogram. The low-risk group received only the usual antimicrobial
prophylaxis.
Results: Positive bile cultures were significantly more frequent in high-risk patients (81% versus 12%;
P < 0.001). The overall rate of infectious complications was lower in the high-risk group (29% versus 46%;
P = 0.018). The statistically significant decrease in the rate of infectious complications reflected reduced
rates of urinary tract infections, pulmonary infections and septicaemia. Rates of wound infection (3%
versus 5%; P = 0.639) and intra-abdominal abscess (7% versus 7%; P = 0.886) were similar in the high-
and low-risk groups, as was the need for curative AMT.
Conclusions: This exploratory study suggests that a postoperative short course of AMT in patients at
high risk for biliary contamination reduces the overall rate of infectious complications after PD. The
adaptation of perioperative antimicrobial policy to the patient's risk for bile contamination seems prom-
ising and should be further evaluated.
Received 30 July 2012; accepted 15 October 2012
Correspondence
Alain Sauvanet, Department of Hepatobiliary and Pancreatic Surgery, Hospital Beaujon, 100 Boulevard du
Général Leclerc, 92110 Clichy, France. Tel: + 33 1 40 87 58 95. Fax: + 33 1 40 87 17 24. E-mail: alain.
sauvanet@bjn.aphp.fr
Introduction
Thanks to improvements in surgical techniques and perioperative
management, pancreaticoduodenectomy (PD) is now routinely
performed in high-volume centres with mortality rates ranging
from <3% to 5%.1,2 Nevertheless, perioperative morbidity is still
substantial and affects up to 60% of patients.1–4 Pancreatic fistula5
and delayed gastric emptying (DGE)6 account for most periop-
erative morbidity and their prevention after PD has been widely
studied, including in numerous prospective randomized trials.7–10
In addition, infectious complications are also frequent, affecting
around 35% of patients4,11,12 with deleterious consequences, but to
date these events have been poorly investigated. Preoperative bile
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contamination is a well known and important risk factor for
infectious complications.13–17 This condition is frequent in malig-
nant ampulloma18–20 and following endoscopic procedures,21
which are still widely performed16 despite evidence-based limita-
tions in indications.22 Overall, it would make sense to actively
reduce the occurrence of infectious complications in this high-
risk group of patients because such a reduction would decrease
overall postoperative morbidity and hospital length of stay (LoS)
following PD.
Previously, the usual antimicrobial prophylaxis (AMP) used for
PD has been shown to be frequently inefficient against microor-
ganisms present in contaminated bile. This may explain the higher
rate of infectious complications in this setting,18 confirmed in
several high-volume centres.15–17 In order to prevent infectious
complications in high-risk patients, the use of a broader empiric
antimicrobial therapy (AMT) administered for a longer period
might be promising. Consequently, the aim of the present study
was to assess the effects on the postoperative occurrence of infec-
tious complications of a short course of appropriate postoperative
AMT in patients at risk for bile contamination.
Materials and methods
Patient selection
From 2004 to 2009, 175 consecutive patients underwent PD for
periampullary malignancy involving either malignant ampulloma
or pancreatic head adenocarcinoma. Patients with benign
tumours were excluded from this study because they are almost
never jaundiced and rarely need PD. Patients with percutaneous
transhepatic biliary drainage were also excluded in order to ensure
that the present analysis included only a homogeneous group of
patients with endogenous bile contamination.
Patients were classified according to their preoperative risk for
the presentation of a positive intraoperative bile culture (PIBC).
Patients were considered at risk for PIBC (high-risk group, n = 99)
if they had a malignant ampulloma18–20 or if they underwent at
least one preoperative endoscopic procedure including sphincter-
otomy, brushing, endoprosthesis or nasobiliary drain.11,18 Patients
were considered without risk for PIBC if they had a pancreatic
head adenocarcinoma and did not submit to a preoperative endo-
scopic procedure (low-risk group, n = 76). Groups were compared
for the occurrence of postoperative complications, with specific
attention to infectious complications. Data were obtained from a
prospective database and additional retrospective medical records
were reviewed when necessary.
Surgical procedure and postoperative management
Pancreaticoduodenectomy without pylorus preservation was per-
formed with regional lymphadenectomy and pancreaticogastros-
tomy, as previously described.23 The abdominal cavity was
routinely drained using an open multichannel silicone drain.
Octreotide (Sandostatin®; Novartis France SA, Rueil Malmaison,
France) was given to patients with a soft pancreas and started
intraoperatively (100 mg subcutaneously three times per day).
Oral diet was initiated on postoperative day (PoD) 5 in patients
without pancreatic leak or other intra-abdominal complication.
Antimicrobial prophylaxis and therapy
According to the institutional protocol for AMT, patients without
risk for PIBC (low-risk group, n = 76) received intraoperative
injections of cefoxitin (2 g i.v. prior to skin incision, then 1 g every
2 h), based on French guidelines for the administration of AMP.24
All patients considered to be at risk for PIBC (high-risk group,
n = 99) received intraoperative AMP, commenced prior to skin
incision, consisting of a combination of gentamicin (5 mg/kg up
to 500 mg in a single shot, n = 99) with piperacillin + tazobactam
(4 g, three times per day, n = 28). The piperacillin + tazobactam
protocol was subsequently switched to ticarcillin + clavulanic acid
(5 g, three times per day, n = 71). This modification was a recom-
mendation of the Institutional Antimicrobials Committee
intended to limit the use of piperacillin + tazobactam in the
setting of AMP because this treatment was already widely used in
AMT. Immediately after abdominal exploration, all patients
underwent bile sampling from the gallbladder and/or the
common bile duct for microbiological culture. No intraoperative
Gram staining was performed. Pathogens were identified with
standard microbiological methods. Antibiotic sensitivity was
tested with Mueller–Hinton agar diffusion.
In patients at risk for bile contamination, empirical AMT was
given until PoD 2, when the results of microbiological culture
became available. If bile culture was negative, AMT was stopped. If
bile culture was positive, AMT was adapted to strain sensitivity
and continued until PoD 5. Empirical AMT was considered
appropriate if all pathogens found in the bile culture were sensi-
tive to either piperacillin + tazobactam or ticarcillin + clavulanic
acid, according to the period of inclusion. Conversely, AMT was
considered inappropriate if microorganisms resistant to the
empirical antibiotics were present, and subsequent treatment
adaptation was required.
Postoperative complications
Postoperative mortality included all deaths occurring before hos-
pital discharge or PoD 90. Morbidity included all complications
following surgery until discharge and/or readmission and were
graded according to the Clavien–Dindo system of classification.25
Major postoperative complications were defined as Clavien–
Dindo Grade III or above. Postoperative pancreatic fistula, haem-
orrhage and DGE were defined according to the International
Study Group of Pancreatic Surgery (ISGPS).26–28 Only clinically
relevant pancreatic fistulae (Grades B or C) were considered.
Infectious complications were defined as bacteriologically posi-
tive culture associated with suggestive clinical symptoms. Wound
infection was defined as the presence of pus requiring wound
opening.29 Intra-abdominal abscess was defined as a postopera-
tive collection treated by puncture or drainage with bacteriologi-
cally positive culture.29 Pulmonary infection was defined as
fever with a suggestive thoracic X-ray image improving under
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antibiotics.30 Bacteraemia was defined as a positive blood culture
bottle with a pathogenic organism.31 For organisms that could
potentially be skin contaminants (i.e. coagulase-negative staphy-
lococci, corynebacteria and Bacillus species), the isolation of the
same bacteria with a similar sensitivity profile from at least two
different sets of blood cultures was required to define a blood-
stream infection.32 Catheter-related bacteraemia was documented
when the blood isolate was cultured from the catheter tip
[103 colony-forming units (CFU)/ml] or when blood cultures
obtained via the catheter were found to be positive at least 2 h
earlier than the corresponding peripheral blood culture.33
Urinary tract infection was defined as suggestive symptoms asso-
ciated with a positive urine culture.34,35 Microorganisms isolated
from postoperative samples were compared with those from
intraoperative bile samples.
Statistical analysis
Quantitative variables were expressed as medians [interquartile
range (IQR)] and compared using the Mann–Whitney U-test.
Qualitative variables were expressed as rates (%) and compared
using the chi-squared test or Fisher’s exact test as appropriate. All
tests were two-sided. Differences were considered statistically sig-
nificant at P < 0.05. Statistical analysis was performed using R
Version 2.13.2 (R Foundation for Statistical Computing, Vienna,
Austria).
Results
Pre- and intraoperative patient characteristics
Characteristics of the patients are detailed in Table 1. There were
no significant differences in demographic characteristics between
the high- and low-risk groups. In the high-risk group, roughly half
of the PDs were performed for pancreatic adenocarcinoma (n =
53, 54%) and half were performed for malignant ampulloma (n =
46, 46%). Patients considered at risk for PIBC were more likely to
have a soft pancreatic remnant (54% versus 34%; P = 0.002).
Endoscopic procedures are detailed in Table 2. Intraoperative data
(Table 3) were comparable across the two groups, except that
perioperative red cell transfusions trended to be higher in the
low-risk group (P = 0.015).
Overall postoperative outcomes
Postoperative outcomes are detailed in Table 3. There was no dif-
ference in postoperative mortality, overall morbidity, rates of
Grade B or C pancreatic fistula or DGE. The median LoS in the
intensive care unit (ICU) was significantly shorter in the high-risk
group (1.0 day versus 2.5 days; P = 0.032), but there was no
significant difference in median hospital LoS (21.0 days versus
21.0 days; P = 0.750).
Infectious complications and microbial aetiology
Postoperative infectious complication was found in 37% (n = 64)
of patients (Table 4).
Table 1 Preoperative characteristics of the patients
Total cohort High-risk group Low-risk group P-valuea
(n = 175) (n = 99) (n = 76)
Male, n (%) 92 (52.6%) 58 (58.6%) 34 (44.7%) 0.096
Age, years, median (range) 62 (55–70) 61 (55–69) 64 (55–71) 0.570
Comorbidities and preoperative blood tests
Diabetes mellitus, n (%) 27 (15.4%) 15 (15.2%) 12 (15.8%) 0.955
Body mass index, kg/m2, median (range) 23.5 (21–26) 24 (21–26) 23 (21–26) 0.806
ASA score 1 or 2, n (%) 156 (89.1%) 87 (87.8%) 69 (90.8%) 0.300
Serum bilirubin, mM/l, median (range) 18 (8.3–90.3) 18 (10.5–56.5) 15 (7.0–316.0) 0.859
Indication for PD, n (%)
Pancreatic adenocarcinoma 129 (73.7%) 53 (53.5%) 76 (100%) <0.001
Ampullary carcinoma 46 (26.3%) 46 (46.5%) 0 <0.001
Tumour diameter, mm, median (range) 30 (20–35) 30 (20–35) 30 (20–35) 0.484
Hard pancreatic remnant, n (%) 96 (54.9%) 46 (46.5%) 50 (65.8%) 0.002
Preoperative endoscopic procedures, n (%) 76 (43.4%) 76 (76.8%) 0 <0.001
aValues in bold are significant at P < 0.05.
ASA, American Society of Anesthesiologists; PD, pancreaticoduodenectomy.
Table 2 Characteristics of the 76 endoscopic preoperative proce-
dures carried out in the high-risk patient group (n = 99)
Type of procedure, n (%)
Endoprosthesis 66 (86.8%)
Sphincterotomy 6 (7.9%)
Nasobiliary drain 1 (1.3%)
Ampullectomy 2 (2.6%)
Attempt to endoscopic procedure, n (%) 4 (5.3%)
Two endoscopic procedures, n (%) 3 (3.9%)
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Positive bile culture was found in 51% of patients (n = 89).
Patients considered at risk for PIBC (high-risk group) showed a
positive bile culture more frequently (81%, n = 80) than patients
in the low-risk group (12%, n = 9) (P < 0.001). Of patients who
did not undergo a preoperative endoscopic procedure, patients
with an ampullary carcinoma were significantly more likely to
have a PIBC than patients with an adenocarcinoma [34 of 46
(74%) patients versus nine of 76 (12%) patients; P < 0.001]. The
microorganisms most commonly isolated in the bile culture were
Enterococcus species (48%), Escherichia coli (42%) and Klebsiella
species (28%); their sensitivities to different antibiotherapy regi-
mens are shown in Table 5. In more than half of patients (66%,
n = 59), more than one pathogen was identified in the bile culture.
This did not differ according to tumour histology [20 of 34 (59%)
patients with ampulloma versus 39 of 55 (71%) patients with
adenocarcinoma; P = 0.241].
The empirical AMT in the high-risk group (ticarcillin + clavu-
lanic acid or piperacillin + tazobactam) was appropriate in 67% (n
= 66) of patients. The initial regimen was found to be inappropri-
ate in patients with infections caused by E. coli (14%, n = 14) and
Staphylococcus species (14%, n = 14). In patients with a PIBC who
developed a postoperative infectious complication, pathogens
found in the intraoperative bile culture were identified as respon-
sible for bacteriologically proven postoperative infection in 11 of
Table 3 Intraoperative and postoperative characteristics of the patients
Total cohort High-risk group Low-risk group P-valuea
(n = 175) (n = 99) (n = 76)
Intraoperative bile contamination, n (%) 89 (50.9%) 80 (80.8%) 9 (11.8%) 0.001
Operative time, min, median (range) 450 (380–540) 460 (390–540) 430 (360–512.5) 0.270
Intraoperative blood loss, ml, median (range) 410 (300–600) 400 (300–625) 475 (300–600) 0.910
Transfusions of red blood cells, units, median (range) 0 (0–0) 0 (0–0) 0 (0–2) 0.015
Mortality, n (%) 6 (3.4%) 1 (1.0%) 5 (6.6%) 0.117
Overall morbidity, n (%) 122 (69.7%) 67 (67.7%) 55 (72.4%) 0.250
Major morbidity, n (%) 40 (22.9%) 20 (20.2%) 20 (26.3%) 0.404
Infectious complications, n (%) 64 (36.6%) 29 (29.3%) 35 (46.1%) 0.018
Pancreatic fistula (Grades B + C), n (%) 24 (13.7%) 17 (17.2%) 7 (9.2%) 0.179
Associated with infected collection 7 5 2 1
Delayed gastric emptying, n (%) 18 (10.3%) 12 (12.1%) 6 (7.9%) 0.506
Haemorrhage, n (%) 14 (8.0%) 7 (7.1%) 7 (9.2%) 0.799
Clostridium difficile colitis, n (%) 1 (0.6%) 1 (1%) 0 1
Length of stay, days, median (range)
Intensive care unit 1.0 (0–5.0) 1.0 (0–4.0) 2.5 (0.8–6.3) 0.032
Hospital stay 21 (16–28) 21 (15–28) 21 (16–27) 0.750
aValues in bold are significant at P < 0.05.
Table 4 Detailed postoperative infectious complications
Total cohort High-risk group Low-risk group P-valuea
(n = 175) (n = 99) (n = 76)
Infectious complications, n (%) 64 (36.6%) 29 (29.3%) 35 (46.1%) 0.018
Surgical site infection, n (%) 19 (10.8%) 10 (10.1%) 9 (11.8%) 0.729
Abscess, n (%)
Wound 7 (4.0%) 3 (3.0%) 4 (5.3%) 0.639
Intra-abdominal 12 (6.9%) 7 (7.1%) 5 (6.6%) 0.886
Pneumonia, n (%) 14 (8.0%) 2 (2.0%) 12 (15.8%) 0.001
Bacteraemia, n (%) 27 (15.4%) 11 (11.1%) 16 (21.1%) 0.030
CRBSI, n (%) 10 (5.7%) 4 (4.0%) 6 (7.9%) 0.370
Urinary tract infection, n (%) 18 (10.3%) 4 (4.0%) 14 (18.4%) 0.002
Antibiotherapy > 7 days, n (%) 41 (23.4%) 18 (18.2%) 23 (30.3%) 0.081
aValues in bold are significant at P < 0.05.
CRBSI, catheter-related bloodstream infection.
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32 patients. Among patients who developed a bacteriologically
proven postoperative infectious complication, the analysis of bac-
teriological samples revealed similar rates of antibiotic-resistant
microorganisms in the high- and low-risk groups [in eight of 29
(28%) patients and eight of 35 (23%) patients, respectively; P =
0.664]. In the high-risk group, half of the antibiotic-resistant
germs responsible for infectious complications were already
present in the bile culture. No late resistant infection was observed
in the high-risk group.
Among low-risk patients, 12% (n = 9) had PIBC. No predictive
factors for PIBC in the low-risk group were identified. Patients
with PIBC received, in addition to the one-shot antimicrobial
cefoxitin prophylaxis, a 5-day AMT course started on PoD 2 and
adapted to the antibiogram. These patients did not develop post-
operative infectious complications more frequently than low-risk
patients with negative bile culture [five of nine (56%) patients
versus 30 of 67 (45%) patients; P = 0.542].
Discussion
If the study of targeted strategies to prevent the occurrence of
pancreatic fistula7,8 and DGE9 after PD had not produced uneven
results, such an approach might make sense in the prevention of
postoperative infectious complications. In the present study, the
authors observed that a 5-day postoperative course of AMT in
patients at high risk for biliary contamination was associated with
a significant decrease in the overall occurrence of postoperative
infectious complications compared with that in patients consid-
ered to be at low risk for biliary contamination. With reference
to surgical site infection, high-risk patients presented a non-
significantly different rate of infection, whereas a higher rate had
been expected in line with previous reports.11,16–18 Identified risk
factors for biliary contamination (i.e. malignant ampulloma and
subjection to preoperative endoscopic procedures) appeared to be
accurate as >80% of patients in whom these risk factors were
present had a positive bile culture. Furthermore, the AMT proto-
col for high-risk patients appeared to be bacteriologically appro-
priate in >80% of cases. The present study justifies the application
of a specific AMT policy in patients undergoing PD and suspected
to have a bile duct contamination in order to decrease the overall
rate of postoperative infectious complications.
Bile contamination from the digestive tract is a well-known risk
factor for postoperative infectious complications.1,11,14,18,36,37 This
condition is usually asymptomatic, is only diagnosed on intraop-
erative positive bile culture, and occurs frequently in patients who
undergo preoperative endoscopic procedures15,21 and in patients
with ampullary carcinoma.18 Indeed, rates of bile contamination
in patients with biliary drainage range from 30% to 98%.3,15,38,39
However, despite strong evidence of the negative impact of preop-
erative biliary drainage if serum bilirubin is <250 mM/l,22 most
patients with pancreatic head adenocarcinoma are still referred to
surgery with biliary drainage in place. Ampulloma is frequently
associated with bile contamination as indicated by the occurrence
of cholangitis in up to 20% of patients.18–20 This is likely to reflect
sphincter dysfunction,18,19,40–42 as well as the need for numerous
preoperative endoscopic procedures in the preoperative workup
of ampulloma.41
In order to prevent the occurrence of postoperative infectious
complications associated with bile contamination, the present
authors propose the specific administration of a 5-day course of
postoperative AMT in high-risk patients. The rationale for this
treatment is firstly that the frequent bile leakage in the operative
field after common bile duct section is likely to contaminate the
postoperative fluid collection that is frequently observed after
pancreatic surgery. Overall, this surgical procedure can be viewed
as an Altemeier class 3 procedure,43 which justifies the provision of
AMT as previously shown with other procedures such as colorec-
tal surgery.44 Secondly, pathogens responsible for bile contamina-
Table 5 Microbial aetiology and antibiotic sensitivity in positive intraoperative bile cultures in 89 patients
Germs Patients,
n (%)









Cefoxitin Gentamicin Amikacin Ciprofloxacin
Enterococcus sp. 43 (48%) 90% 90% 90% 90% 0% 0% 0% 0%
Escherichia coli 37 (42%) 60% 80% 80% 90% 90% 90% 100% 90%
Klebsiella sp. 25 (28%) 0% 90% 90% 90% 100% 100% 100% 90%
Hafniae alvei 10 (11%) 0% 0% 100% 100% 90% 100% 100% 100%
Enterobacter sp. 9 (10%) 0% 0% 90% 90% 90% 100% 100% 90%
Streptococcus sp. 8 (9%) 60% 60% 60% 60% 80% 0% 0% 0%
Pseudomonas
aeruginosa
8 (9%) 10% 10% 60% 90% 50% 60% 90% 80%
Staphylococcus sp. 7 (8%) 0% 70% 70% 70% 70% 90% 90% 70%
Proteus sp. 6 (7%) 0% 100% 100% 100% 100% 100% 100% 100%
Morganella morganii 4 (5%) 0% 0% 100% 100% 100% 100% 100% 100%
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tion in high-risk patients have been shown to differ from
pathogens isolated from bile culture in non-health care-associated
biliary infections.18,45,46 These pathogens must be targeted appro-
priately. The systematic policy evaluated in the present study was
found to be associated with a reduced rate of infectious compli-
cations after PD in selected patients (i.e. patients who underwent
preoperative endoscopic procedures or patients with ampullary
carcinoma). Interestingly, as a result of this active prevention
strategy, high-risk patients demonstrated an even lower overall
rate of infectious complications than patients without risk. Rates
of wound and intra-abdominal infections, which, on the basis of
previous evidence,11,15–18 were expected to be higher in the high-
risk group, were similar across the two groups, confirming the
efficacy of this preventive strategy. This efficient preventive strat-
egy may prove even more interesting when PD is performed
without postoperative drainage, as the potentially intraoperatively
infected fluid remains intra-abdominal. This decrease in postop-
erative infectious complications was also associated with a shorter
stay in the ICU.
The microorganisms most frequently isolated in bile samples
were Enterococcus species, E. coli and Klebsiella species; this is
similar to findings reported in previous studies.3,45–47 A compari-
son of the microorganisms identified in bile cultures and those
identified in cultures obtained from postoperative wound and
intra-abdominal infections showed identical microorganisms in
about half of cases, which suggests that at least a third of overall
infectious complications are caused by preoperatively contami-
nated bile. Interestingly, in the no-risk group, 12% of patients had
a positive bile culture. No risk factor for this finding could be
identified and thus routine intraoperative bile sampling in all
patients undergoing PD is justified.
The national French guidelines for surgical AMP recommend
the use of only second-generation cephalosporin for PD.24 Based
on pathogens isolated in bile culture in high-risk patients, this
treatment would have led to inappropriate AMP in 57% of
patients. Similarly, in a high-volume North American centre, the
use of second-generation cephalosporin as AMP was not associ-
ated with a lower rate of infectious complications in high-risk
patients.15 Results demonstrated that other antimicrobial agents
and administration should be considered.15 In view of the local
microbial ecology, the combination of carboxy or ureido penicil-
lin and gentamicin was considered suitable for the most fre-
quently isolated pathogens (i.e. ampicillin-sensitive enterococcus
and Gram-negative bacteria). Extended-spectrum beta-lactamase
(ESBL) pathogens were infrequent and did not appear to justify a
further enlargement of this protocol.15
The authors are aware of some limitations of the current study.
Firstly, from a methodological point of view, only a four-arm,
randomized controlled study (which also tested standard AMP in
high-risk patients and broad AMT in low-risk patients in an intent-
to-treat analysis) would support the drawing of definitive conclu-
sions. Nevertheless, such a trial cannot occur without results from
preliminary studies such as this. Secondly, the present study design
cannot determine whether the decrease in infection rate relates to
the initial broad empiric ABT or to the subsequent adaptation. The
duration of ABT should also be investigated because of its potential
impact on microbial ecology and strain resistance, even if this was
not observed in the present experience. From this perspective, as
previously reported,3 intraoperative bile culture and antibiogram
should only be used to treat postoperative symptomatic infection.
This latter policy is theoretically less likely to influence the respec-
tive bacteriological ecology, but it remains a therapeutic and not a
preventive strategy. It is important to note that the present policy
was also associated with a decrease in non-bile-related infections
such as urinary tract infections and pneumonia, which resulted in
an overall clinical benefit to patients. A last option for the preven-
tion of postoperative infectious complications in patients at risk
would involve the use of AMP45 guided by preoperative bile culture.
However, this policy is only possible in patients in whom percuta-
neous or endoscopic nasobiliary drains are placed and these are
used less frequently than endoscopic biliary stenting because of the
associated increase in morbidity.48
In conclusion, bile contamination is frequent in patients with
periampullary neoplasm, especially following preoperative biliary
drainage, and in patients with malignant ampulloma. This justi-
fies the routine intraoperative sampling of bile for bacteriological
documentation in all patients undergoing PD. Specific postopera-
tive AMT seems to be efficient in preventing infectious complica-
tions in these high-risk patients. The benefits and consequences of
such a policy should be evaluated prospectively on a larger scale,
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